The Activin/FLRG Pathway Associates with Poor COVID-19 Outcomes in Hospitalized Patients.

Mol Cell Biol · 2022 · PMC8773081 · PMID 34723652

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In one experiment, there was less mortality with the anti-activin A antibody versus the negative control, although this did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.